Short Interest in Aspen Aerogels, Inc. (NYSE:ASPN) Increases By 9.4%

Aspen Aerogels, Inc. (NYSE:ASPN) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 9,820,000 shares, a growth of 9.4% from the December 15th total of 8,980,000 shares. Based on an average daily volume of 2,470,000 shares, the days-to-cover ratio is currently 4.0 days.

Aspen Aerogels Stock Up 1.3 %

ASPN traded up $0.17 on Monday, hitting $12.73. 1,371,812 shares of the company were exchanged, compared to its average volume of 1,388,320. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.04 billion, a price-to-earnings ratio of 1,273.77 and a beta of 2.14. The firm has a 50-day moving average price of $13.47 and a two-hundred day moving average price of $20.18. Aspen Aerogels has a twelve month low of $10.75 and a twelve month high of $33.15.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently made changes to their positions in the stock. Driehaus Capital Management LLC grew its holdings in Aspen Aerogels by 130.4% during the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock worth $51,439,000 after acquiring an additional 1,220,724 shares in the last quarter. FMR LLC lifted its holdings in Aspen Aerogels by 23.6% during the 3rd quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock worth $112,169,000 after buying an additional 773,647 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of Aspen Aerogels by 562.3% in the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after acquiring an additional 654,350 shares during the last quarter. Millennium Management LLC acquired a new stake in shares of Aspen Aerogels during the 2nd quarter worth about $9,339,000. Finally, Lord Abbett & CO. LLC purchased a new stake in Aspen Aerogels during the third quarter worth approximately $10,126,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ASPN. Piper Sandler cut their target price on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Canaccord Genuity Group decreased their target price on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating on the stock in a research report on Thursday. HC Wainwright reiterated a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a research report on Wednesday, October 16th. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. Finally, Barclays dropped their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Aspen Aerogels currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.11.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.